PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: biology

Clinical study protocol template

Global Clinical Development - General Medicine QAW039/fevipiprantClinical Trial protocol CQAW039A2316 / NCT03215758A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthmaDocument type: Clinical Trial ProtocolEUDRACT number:2017-001273-16 Version number:00 (OriginalProtocol) Clinical trial phase:IIIR elease date:10- May-2017 Property of NovartisConfidentialMay not be used, divulged, published, or otherwise disclosedwithout the consent of NovartisClinical Trial protocol template Version (July 2016)NovartisConfidentialPage 2 Clinical Trial protocol (Version 00) protocol No.

PRO patient reported outcome PT prothrombin time QM quality management QOL quality of life QTcF Fridericia QT correction formula RAST radioallergosorbent test SABA short-acting -agonist SAE(s) serious adverse event(s) SAF safety analysis set sCr serum creatinine SCR screening SD standard deviation SJS Stevens-Johnson syndrome SoC standard of care

Fullscreen Download
Loading..

Tags:

  Patients, Outcome, Reported, Patient reported outcome

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Clinical study protocol template

Documents from same domain

Research Proposal - ClinicalTrials.gov

clinicaltrials.gov

as fecal microbiota transplantation (FMT). 4. Procedures Tissue samples will be obtained from consenting patients at (SDMCUT), or other relevant facilities (see section 6.i below), in accordance with protocols approved by the University of Texas Institutional Review Board (UTIRB). Patients who meet eligibility criteria will have their

  Research, Proposal, Fecal, Microbiota, Transplantation, Research proposals, Fecal microbiota transplantation

Novartis CSR template

clinicaltrials.gov

9.1 Study design Figure 9-1 Study design BID: twice a day, QD: once a day. This was a multicenter, randomized, double-masked, two-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who were insufficiently controlled on travoprost 0.004% (Travatan) monotherapy. Approximately 200 patients were planned to be

  Design, Study, Parallel, Study design

DETAILED STATISTICAL ANALYSIS PLAN (SAP)

clinicaltrials.gov

Statistical principles : 4.1. Multiplicity : The diagnostic and prognostic basic stud y and each sub -study consist of one primary outcome and one or more secondary, exploratory outcomes. We will encounter multiplicity issues due to the multiple

  Principles, Statistical, Statistical principles

A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …

clinicaltrials.gov

conjunction with Ceramic on Ceramic and Taperloc Complete Microplastyarticulation stem in primary total hip arthroplasty compared to patients who received the Exceed ABT Acetabular system with the same combination.

  System, Complete, Taperloc, Taperloc complete

Statistical Analysis Plan (SAP) - ClinicalTrials.gov

clinicaltrials.gov

statistical analysis. The subsections below will describe analyses in addition to the descriptive statistics. 6.1 Primary outcome The primary analysis will compare intervention groups (water supplementation vs control treatment) on their mean change in fasting plasma glucose between baseline and 12 months using a linear mixed model.

  Analysis

New antibiotic treatment options for uncomplicated ...

clinicaltrials.gov

treatment options for gonorrhoea and only a few new drugs in the development pipeline, it is important to test existing antibiotics for their efficacy in gonorrhoea treatment. Objective : This project aims to identify new treatment modalities for uncomplicated gonorrhoea using

  Gonorrhoea

Title: A Phase 1, Randomized, Double-Blind, Placebo ...

clinicaltrials.gov

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects Phase 1 TAK-653 Escalating Single and Multiple Dose Study in Healthy Subjects Sponsor: Takeda Development Centre Europe Ltd. 61 Aldwych London, WC2B 4AE United Kingdom

  Controlled, Double, Blind, Placebo, Randomized, Double blind, Placebo controlled

A Phase II, Randomized, Double -blind, Placebo -controlled ...

clinicaltrials.gov

• International Conference on Harmonisation, E6 Good Clinical Practice: Consolidated Guideline. • All applicable laws and regulations, including, without limitation, data privacy laws and regulations. • Regulatory requirements for reporting serious …

  Good, Practices, Clinical, Good clinical practice

Clinical Study Report (CSR) Template (Drug and Device)

clinicaltrials.gov

ATC Anatomical Therapeutic Chemical CFB change from baseline DHA dapsone hydroxylamine eCRF electronic case report form IGA Investigator’s Global Assessment MedDRA Medication Dictionary for Regulatory Activities mITT modified intent-to-treat NAD N-acetyl dapsone PK pharmacokinetic ...

  Chemical, Therapeutic, Anatomical, Anatomical therapeutic chemical

Title: TWILIGHT Study - Ticagrelor With Aspirin or Alone ...

clinicaltrials.gov

Prior stroke Dialysis-dependent renal failure Active bleeding or extreme-risk for major bleeding (e.g. acute ... Life expectancy < 1 year ... 7.3.4 Adverse Events based on signs and symptoms ...

  Based, Life, Stroke, Life expectancy, Expectancy

Related documents

QOLに関するPatient Reported Outcomeの評価

archive.jsco.or.jp

QOLに関するPatient Reported Outcomeの評価 1．はじめに がん治療の評価には生存期間や抗腫瘍効果といった 客観的な指標が主に用いられる。それら客観的評価に 加えて患者の視点にたった指標であるQuality of Life （QOL） も評価される臨床試験が多くなっている。延命

  Reported, Qolに関するpatient reported outcomeの評価, Qolに関するpatient, Outcomeの評価

Clinical Practice Guidelines

www.orthopt.org

EXAMINATION – OUTCOME MEASURES: ACTIVITY LIMITATIONS AND SELF-REPORTED MEASURES B Clinicians should use the International Knee Documentation Committee 2000 Subjective Knee Evaluation Form (IKDC 2000) or Knee injury and Osteoarthritis Outcome Score (KOOS), and may use the Lysholm scale, as validated patient-reported outcome

  Patients, Outcome, Reported, Reported outcomes

The Communicative Participation Item Bank – General Short …

ancds.memberclicks.net

– “QOL is a critical outcome following any intervention…the initial evaluation focuses on the patient's lifestyle and activities of importance to them ….” [L12] – ... Parkinson’s disease Self‐reported speech ...

  Patients, Outcome, Reported

Related search queries

QOLに関するPatient Reported Outcomeの評価, Outcome, Reported, Patient, Reported outcome